BOONE CAPITAL MANAGEMENT LLC
Clone Performance
Aug 2023–Aug 2026 · vs SPYHypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.
Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. Returns use comparable raw closes and exclude dividends; a captured split can shorten the simulated window. It tracks 100% of reported value on average across 13 quarters. Past performance does not predict future results.
Portfolio Concentration
16 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Portfolio Trend
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 93.5% | $399,946,255 |
| Industrials | 6.5% | $27,590,032 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| BBIO | BridgeBio Pharma, Inc. | +110,891 | 339,720 | $25,302,345 | |
| TFX | Teleflex Inc | +108,596 | 387,388 | $49,105,302 | |
| KOD | Kodiak Sciences Inc. | +96,678 | 378,010 | $14,727,269 | |
| GRDN | Guardian Pharmacy Services, Inc. | +80,746 | 711,939 | $29,808,885 | |
| BMRN | Biomarin Pharmaceutical Inc | +35,348 | 583,219 | $33,371,791 | |
| CI | Cigna Group | +21,768 | 159,290 | $43,913,067 | |
| IONS | Ionis Pharmaceuticals Inc | +19,455 | 519,977 | $41,228,976 | |
| UNH | Unitedhealth Group Inc | +9,461 | 88,687 | $36,860,977 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| MIRM | Mirum Pharmaceuticals, Inc. | −5,595 | 415,641 | $48,659,091 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| VSTS | Vestis Corp | 1,900,140 | $27,590,032 | |
| PNTG | Pennant Group, Inc. | 515,818 | $19,059,475 | |
| GLUE | Monte Rosa Therapeutics, Inc. | 615,287 | $14,889,945 | |
| TNGX | Tango Therapeutics, Inc. | 455,605 | $14,242,212 | |
| KYMR | Kymera Therapeutics, Inc. | 113,173 | $12,977,547 | |
| CGEM | Cullinan Therapeutics, Inc. | 704,442 | $12,827,888 | |
| ANL | Adlai Nortye Ltd. | 258,390 | $2,971,485 | |
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| TFX |
Teleflex Inc
Healthcare
|
Added | 387,388 | $49,105,302 | 11.49% | |
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
Reduced | 415,641 | $48,659,091 | 11.38% | |
| CI |
Cigna Group
Healthcare
|
Added | 159,290 | $43,913,067 | 10.27% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
Added | 519,977 | $41,228,976 | 9.64% | |
| UNH |
Unitedhealth Group Inc
Healthcare
|
Added | 88,687 | $36,860,977 | 8.62% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Added | 583,219 | $33,371,791 | 7.81% | |
| GRDN |
Guardian Pharmacy Services, Inc.
Healthcare
|
Added | 711,939 | $29,808,885 | 6.97% | |
| VSTS |
Vestis Corp
Industrials
|
NEW | 1,900,140 | $27,590,032 | 6.45% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Added | 339,720 | $25,302,345 | 5.92% | |
| PNTG |
Pennant Group, Inc.
Healthcare
|
NEW | 515,818 | $19,059,475 | 4.46% | |
| GLUE |
Monte Rosa Therapeutics, Inc.
Healthcare
|
NEW | 615,287 | $14,889,945 | 3.48% | |
| KOD |
Kodiak Sciences Inc.
Healthcare
|
Added | 378,010 | $14,727,269 | 3.44% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
NEW | 455,605 | $14,242,212 | 3.33% | |
| KYMR |
Kymera Therapeutics, Inc.
Healthcare
|
NEW | 113,173 | $12,977,547 | 3.04% | |
| CGEM |
Cullinan Therapeutics, Inc.
Healthcare
|
NEW | 704,442 | $12,827,888 | 3.00% | |
| ANL |
Adlai Nortye Ltd.
Healthcare
|
NEW | 258,390 | $2,971,485 | 0.70% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.